These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30274073)

  • 1. Mesoporous silicas templated by heterocyclic amino acid derivatives: Biomimetic synthesis and drug release application.
    Li H; Ke J; Li H; Wei C; Wu X; Li J; Yang Y; Xu L; Liu H; Li S; Yang M; Wei M
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():407-418. PubMed ID: 30274073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.
    Li J; Xu L; Yang B; Bao Z; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2015 Oct; 55():367-72. PubMed ID: 26117767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and preparation of mesoporous silica carriers with chiral structures for drug release differentiation.
    Wang Y; Li W; Liu T; Xu L; Guo Y; Ke J; Li S; Li H
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109737. PubMed ID: 31349514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
    Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic synthesized bimodal nanoporous silica: Bimodal mesostructure formation and application for ibuprofen delivery.
    Li J; Xu L; Zheng N; Wang H; Lu F; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1105-11. PubMed ID: 26478410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of biomimetically synthesized mesoporous silica nanoparticles as drug carriers: Structure, wettability, degradation, biocompatibility and brain distribution.
    Li H; Wu X; Yang B; Li J; Xu L; Liu H; Li S; Xu J; Yang M; Wei M
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():453-464. PubMed ID: 30423730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
    Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
    J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoassemblies constructed from bimodal mesoporous silica nanoparticles and surface-coated multilayer pH-responsive polymer for controlled delivery of ibuprofen.
    Guo Y; Sun J; Bai S; Jin X
    J Biomater Appl; 2016 Sep; 31(3):411-20. PubMed ID: 27278781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
    Czarnobaj K; Prokopowicz M; Sawicki W
    AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel functional mesoporous silica nanoparticles loaded with Vitamin E acetate as smart platforms for pH responsive delivery with high bioactivity.
    Mai Z; Chen J; Hu Y; Liu F; Fu B; Zhang H; Dong X; Huang W; Zhou W
    J Colloid Interface Sci; 2017 Dec; 508():184-195. PubMed ID: 28841476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug.
    Li J; Xu L; Yang B; Wang H; Bao Z; Pan W; Li S
    Int J Pharm; 2015 Aug; 492(1-2):191-8. PubMed ID: 26163764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
    Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
    Li J; Xu L; Wang H; Yang B; Liu H; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
    Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
    J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
    Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
    Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug.
    Zhai QZ
    J Microencapsul; 2013; 30(2):173-80. PubMed ID: 22894165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion and release of fenbufen in mesoporous silica.
    Carriazo D; del Arco M; Fernández A; Martín C; Rives V
    J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.